Skip to content

Starfighters Space, Inc. FJET Proceeds From Regulation Financing

Proceeds From Regulation Financing at other companies

Nuvation Bio logo
Nuvation BioNUVB
$864K
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
American Battery Technology Company logo
American Battery Technology CompanyABAT
$3.75M
Wyndham Hotels & Resorts, Inc. logo
Wyndham Hotels & Resorts, Inc.WH
$3M+71.4%
Delek US Holdings logo
Delek US HoldingsDK
$268.6M-25.8%
Opus Genetics logo
Opus GeneticsIRD
$5.75M

Other financials

Income statement

See full
Net income-$4.3M-60.9%
EPS (diluted)-$0.10+23.1%

Balance sheet

See full
Cash & equivalents$1.4M-65.0%
Total debt$477.5K
Total equity$22.4M+593%
Total assets$26.3M

Cash flow

See full
Operating cash flow-$4.0M-137%
CapEx$37.7K
Free cash flow-$2.1M-117%

Valuation

See full
Market cap$264.01M-30.2%
Enterprise value$263.09M

Returns & leverage

See full
Return on equity-203.1%
Debt / equity
Current ratio5.2×

Where this comes from

Reported directly by Starfighters Space, Inc. in its filing.

Tagged under the XBRL concept fjet:ProceedsFromRegulationFinancing.

The official record: Starfighters Space, Inc. ’s 10-K, filed April 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Starfighters Space, Inc. 's proceeds from regulation financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Starfighters Space, Inc. 's proceeds from regulation financing?
Starfighters Space, Inc. (FJET) reported proceeds from regulation financing of $1.81M in Q4 2025.
How has Starfighters Space, Inc. 's proceeds from regulation financing changed year-over-year?
Starfighters Space, Inc. 's proceeds from regulation financing decreased by 32.2% year-over-year, from $2.67M to $1.81M.
What does proceeds from regulation financing mean?
This represents cash inflows derived from specific regulatory-compliant financing rounds or government-backed capital initiatives. It highlights the company's ability to leverage specialized funding frameworks to support growth and operational scaling.